Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: wheat associated mycobiome

PROVIDER: PRJNA718428 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR14123800.fastq.gz	Fastqsanger.gz
	SRR14123900.fastq.gz	Fastqsanger.gz
	SRR14124000.fastq.gz	Fastqsanger.gz
	SRR14123801.fastq.gz	Fastqsanger.gz
	SRR14123901.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 371

Similar Datasets

wheat straw residus

Project description:mycobiome of wheat straw residues

| PRJNA624995 | ENA

Project description:Fungicides have complex effects on the wheat phyllosphere mycobiome

| PRJNA498985 | ENA

Characterization of the Wheat-Psathyrostachys huashania 2Ns/2D Substitution Line H139: A Novel Germplasm with Enhanced Resistance to Wheat Take-all

Project description:Take-all is a devastating soil-borne disease that affects wheat production. The continuous generation of disease-resistance germplasm is an important aspect of the management of this pathogen. In this study, we characterized the wheat-Psathyrostachys huashania Keng-derived progeny H139 that exhibits significantly improved resistance to wheat take-all disease compared with its susceptible parent 7182. GISH) and mc-FISH analyses revealed that H139 is a stable wheat-P. huashania disomic substitution line lacking wheat chromosome 2D.EST-STS marker and Wheat Axiom 660K Genotyping Array analysis further revealed that H139 was a novel wheat-P. huashania 2Ns/2D substitution line, and that the P. huashania 2Ns chromosome shares high sequence similarity to wheat chromosome 2D. These results indicate that H139, with its enhanced wheat take-all disease resistance and desirable agronomic traits, provides valuable genetic resources for wheat chromosome engineering breeding.

2020-01-07 | GSE143188 | GEO

Project description:Host factors associated with gut mycobiome structure

| PRJNA850529 | ENA

Project description:Root associated mycobiome of different watermelon cultivars

| PRJNA643411 | ENA

mRNA oxidation data from dry dormant and after-ripened wheat seeds

Project description:After-ripening induced seed dormancy release in wheat is associated with mRNA oxidation. We used Affymetrix GeneChip Wheat Genome Array to identify mRNAs differentially oxidized by after-ripening

2013-12-15 | GSE41949 | GEO

Project description:Stability of the Wheat Seed Mycobiome Along North Carolina's Longitudinal Gradient

| PRJNA1077707 | ENA

Project description:Spatiotemporal dynamics and mycobiome networks in the canopy of wheat cultivars

| PRJNA393388 | ENA

Effects of the fungicide penconazole on the leaf associated aquatic mycobiome in stream channels and flask microcosms

Project description:Aquatic leaf litter associated mycobiome under fungicide stress

| PRJEB77411 | ENA

The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors

Project description:This phase I clinical trial tests the immune effects of fermented wheat germ in patients with advanced solid tumor cancers who are being treated with standard of care checkpoint inhibitors. Fermented wheat germ is a nutritional supplement that some claim is a "dietary food for special medical purposes for cancer patients" to support them in treatment. There have also been claims that fermented wheat germ is "clinically proven" and "recognized by medical experts" to "enhance oncological treatment" and boost immune response to cancer; however, there are currently no documented therapeutic effects of fermented wheat germ as a nutritional supplement. Checkpoint inhibitors, given as part of standard of care for advanced solid tumors, are a type of immunotherapy that may help the body’s immune system attack the cancer and may interfere with the ability of tumor cells to grow and spread. The information gained from this trial may allow researchers to determine if there is any value of giving fermented wheat germ with standard of care checkpoint inhibitors for patients with advanced solid tumor malignancies.

| 68011 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data